Volta Finance’s portfolio is built to withstand stress, but markets don’t always price that in. Mark Thomas of Hardman & Co explains how CLO structures, diversification and active management are..
AI governance is becoming a practical indicator of how well pharma companies can adopt new technology while controlling regulatory, operational and reputational risk...
While recent returns have been subdued, the Trust maintains strong long-term performance, delivering substantial gains since manager appointment and steady dividend growth over five years...
CMC Markets is widening access beyond standard trading hours, using weekend gold and extended US equities trading to strengthen its multi-asset platform for active clients...
Asian investors looked past fresh Middle East tension and kept backing technology and AI-led growth, showing that earnings confidence is still outweighing geopolitical caution for now...
Uranium is back in focus as stronger nuclear demand, tight supply and energy security concerns make the wider nuclear value chain more relevant for investors...
FTSE 100 falls as Hormuz disruption lifts oil prices, boosting energy stocks but reviving inflation fears and weighing on miners, housebuilders and travel names...
Ilika’s Brompton development programme gives investors a more direct read on whether its solid-state battery technology can win real-world commercial use...
GenFlow Biosciences is making its longevity strategy more investable by backing the science with practical choices on manufacturing, platform design and regulatory progress...
Lime remains a basic but important reagent in mineral processing because it affects pH control, mineral separation, froth behaviour and wider site management...
The UK IT services provider said it delivered strong second-half growth across its divisions, lifted Workday Products ARR above £89 million and expects FY26 revenue ahead of consensus with adjusted..
Plus500 reported record customer income of $270.6 million in the first quarter of 2026, supported by higher customer engagement, growth in non-OTC revenue and continued expansion in the US...
Kailera Therapeutics priced a $625 million Nasdaq IPO, marking the largest biotech listing by proceeds and delivering a significant valuation uplift for RTW Biotech Opportunities...
High-level data from the MIRANDA study showed AstraZeneca’s IL-33-targeting biologic tozorakimab significantly lowered annualised moderate-to-severe COPD exacerbations and was generally well tolerated...
The approval covers Blenrep plus bortezomib and dexamethasone for adults with relapsed or refractory multiple myeloma and is supported by phase III DREAMM-7 data showing progression-free and overall survival benefits...
Volta Finance’s portfolio is built to withstand stress, but markets don’t always price that in. Mark Thomas of Hardman & Co explains how CLO structures, diversification and active management are driving resilience, even as sentiment creates sharp NAV and share price swings...
AI governance is becoming a practical indicator of how well pharma companies can adopt new technology while controlling regulatory, operational and reputational risk...
While recent returns have been subdued, the Trust maintains strong long-term performance, delivering substantial gains since manager appointment and steady dividend growth over five years...
CMC Markets is widening access beyond standard trading hours, using weekend gold and extended US equities trading to strengthen its multi-asset platform for active clients...
Asian investors looked past fresh Middle East tension and kept backing technology and AI-led growth, showing that earnings confidence is still outweighing geopolitical caution for now...
Uranium is back in focus as stronger nuclear demand, tight supply and energy security concerns make the wider nuclear value chain more relevant for investors...
FTSE 100 falls as Hormuz disruption lifts oil prices, boosting energy stocks but reviving inflation fears and weighing on miners, housebuilders and travel names...
Ilika’s Brompton development programme gives investors a more direct read on whether its solid-state battery technology can win real-world commercial use...
GenFlow Biosciences is making its longevity strategy more investable by backing the science with practical choices on manufacturing, platform design and regulatory progress...
Lime remains a basic but important reagent in mineral processing because it affects pH control, mineral separation, froth behaviour and wider site management...
The UK IT services provider said it delivered strong second-half growth across its divisions, lifted Workday Products ARR above £89 million and expects FY26 revenue ahead of consensus with adjusted PBT in line with market forecasts...
Plus500 reported record customer income of $270.6 million in the first quarter of 2026, supported by higher customer engagement, growth in non-OTC revenue and continued expansion in the US...
Kailera Therapeutics priced a $625 million Nasdaq IPO, marking the largest biotech listing by proceeds and delivering a significant valuation uplift for RTW Biotech Opportunities...
High-level data from the MIRANDA study showed AstraZeneca’s IL-33-targeting biologic tozorakimab significantly lowered annualised moderate-to-severe COPD exacerbations and was generally well tolerated...
The approval covers Blenrep plus bortezomib and dexamethasone for adults with relapsed or refractory multiple myeloma and is supported by phase III DREAMM-7 data showing progression-free and overall survival benefits...
